Robert Egan, MD
Neurology · Medford, ORNPI 1396771358
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $20,739 of the $31,838 with a category attached, or 65.1%. AbbVie accounts for 75.0% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $21,664 and has fallen 99.6% since, to $80 in 2025. Among neurology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $289.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$24K
- Jazz Pharmaceuticals Inc.$5K
- Sanofi$398
- Lilly USA, LLC$242
- SK Life Science, Inc.$203
- AstraZeneca$179
- plus $2K from 26 others
What the payments were for
- Consulting fees$3,96012%
- Speaking & faculty fees$1,7005%
- Travel & lodging$1,5705%
- Food & beverage$3,80912%
- Education$600%
- Gifts$20,73965%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $23,868 |
| Jazz Pharmaceuticals Inc. | 9 | $5,285 |
| Sanofi | 11 | $398 |
| Lilly USA, LLC | 7 | $242 |
| SK Life Science, Inc. | 2 | $203 |
| AstraZeneca | 2 | $179 |
| Boston Scientific | 1 | $147 |
| Amgen | 5 | $141 |
| EMD Serono, Inc. | 2 | $130 |
| Teva Pharmaceuticals USA, Inc. | 11 | $125 |
| Biogen | 6 | $102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $102 |
| Spark Therapeutics, Inc. | 1 | $101 |
| Biohaven Pharmaceuticals, Inc. | 1 | $100 |
| Johnson & Johnson | 1 | $95 |
| Corium, LLC | 1 | $92 |
| Merz Pharmaceuticals, LLC | 1 | $71 |
| Catalyst Pharmaceuticals, Inc. | 1 | $62 |
| Greenwich Biosciences, Inc. | 1 | $62 |
| Novartis | 4 | $57 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $31 |
| Lundbeck LLC | 1 | $30 |
| Tanabe Pharma America, Inc. | 1 | $29 |
| Acadia Pharmaceuticals Inc | 2 | $28 |
| CSL Behring | 1 | $23 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Medtronic | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,838 in reported general payments places this provider in the 90th percentile of 228 neurology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tegretol XrCarbamazepine | 18 | $4,153 |
| Lamotrigine ErLamotrigine | 21 | $4,073 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 34 | $1,454 |
| Donepezil Hcl | 35 | $766 |
| Lamotrigine | 22 | $743 |
| Levetiracetam | 24 | $730 |
| Duloxetine Hcl | 25 | $726 |
| Memantine Hcl | 27 | $406 |
| Topiramate | 14 | $382 |
| Atorvastatin Calcium | 29 | $351 |
| Rosuvastatin Calcium | 11 | $156 |
Paid to pharmacies, not to this prescriber.
Other neurology in Medford
- Walter CarliniMedford$425K
- Minji KimMedford$28K
- Sulagshan MahendrarajahMedford$4K
- Oscar SanchezMedford$3K
- Jose Rodriguez MorenoMedford$3K
- Pawani SacharMedford$2K
- David ClarkSpringfield$1.1M
- Kyle SmootPortland$932K
- Chafic KaramPortland$727K
- Herbert KrobPortland$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.